CTX611 Trademark
CTX611 is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Pending.
Trademark Facts
| Mark | CTX611 |
|---|---|
| Serial Number | 99583006 |
| Status | Pending |
| Filing Date | 2026-01-07 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 4 |
| Latest Event | DOCK on 2026-05-06 |
Goods & Services
Class 005: Cells for medical or clinical use in the field of gene therapy for the treatment of cardiovascular diseases and thromboembolic diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; Class 042: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of gene therapy